## CEG: Constellation Energy Corporation - XLU: Utilities

### Executive Summary

No thesis match: MRS_10 -1.0% below STRENGTH zone (3.0-6.0%); PEG 3.63 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($323.72)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 4
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Constellation Energy stock rebounds as 2026 begins; what CEG investors watch next**
- Source: ts2.tech | 20260103T162600 | Bullish | Relevance: 100%
- Constellation Energy (CEG) stock rebounded by 3.67% on Friday, January 3, 2026, after a four-session slide, closing at $366.25. This rebound occurred as the broader market opened 2026 higher, with utilities gaining. Investors are now watching upcoming U.S. labor data, a debt-exchange deadline related to the Calpine deal, and February earnings expectations for Constellation.

**2. Energy Fuels raises uranium sales outlook as nuclear stocks cool**
- Source: Mugglehead Magazine | 20260103T010835 | Neutral | Relevance: 67%
- Energy Fuels (NYSE: UUUU) exceeded its 2025 production guidance and secured new long-term sales deals, leading to a bump in its stock price before a broader nuclear sector pullback. The company now expects to sell approximately 360,000 pounds of uranium concentrate in Q4, a 50% increase from the prior year, with projected gross sales revenue of about USD$27 million. Despite the positive news, shares have pulled back from recent highs amidst volatility in the uranium sector, though the long-term outlook for nuclear energy remains strong, especially with increasing interest from AI data centers and government support for domestic uranium production.

**3. Assessing Duke Energy (DUK) Valuation As Conflicting Fair Value Estimates Emerge**
- Source: Simply Wall Street | 20260105T063741 | Neutral | Relevance: 64%
- Duke Energy (DUK) is under investor scrutiny, with its recent stock performance showing a 6.47% decline over 90 days but a 14.40% gain over the last year. Conflicting fair value estimates exist, with one narrative suggesting a 13.8% undervaluation at $136.18 due to its clean energy investments, while a DCF model indicates the current $117.44 price is overvalued with a fair value closer to $64.38. The discrepancy highlights the importance of underlying assumptions in valuation models.

**4. Should Xcel’s Colorado Gas Hike and Craig Plant Extension Reshape Xcel Energy’s (XEL) Risk Equation?**
- Source: Simply Wall Street | 20260105T130828 | Neutral | Relevance: 55%
- Xcel Energy's Colorado subsidiary recently proposed an 11.6% natural gas revenue hike and was ordered to continue operations at the Craig Power Plant's Unit 1. These developments highlight the ongoing challenge of balancing infrastructure investment, managing older fossil fuel assets, and maintaining affordable, reliable service. The article examines how these events could affect Xcel Energy's investment outlook and risk profile, particularly regarding regulatory outcomes and balance sheet pressures.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | UBS | $420 | $385 | +9% |
| 2025-12-16 | JP Morgan | $410 | $422 | -3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | UBS | main | Buy |
| 2025-12-16 | JP Morgan | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 1 ($4.54M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.3% (+0.1%)
- Capital Internationa: 8.4% (-7.3%)
- Blackrock Inc.: 7.2% (+0.8%)
- State Street Corpora: 5.8% (+0.3%)
- FMR, LLC: 4.2% (-6.8%)

### Key Risks

1. Insider selling cluster: $4.5M in recent transactions.
2. Valuation stretched: PEG 3.6x requires aggressive growth execution.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.63 signals overvaluation risk, limited margin of safety. Balance sheet: $1.5B free cash flow. Insider selling cluster ($4.5M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $110.9B |
| Beta | 1.15 |
| 52W Range | $161.35 - $412.70 |
| Short Interest | 2.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.63 |
| Forward P/E | 31.1 |
| Current P/E | 38.1 |
| YoY Growth | 22.7% |
| EPS Direction | STABLE |

### Technicals

MRS_10 stable at -1.0% (minimal 5-day change). Below STRENGTH zone by 4.0pp (needs >3.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.13x) but short-term weakness (below SMA20). RSI neutral at 48. OFD pattern: -MTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.97% (CS: 24) | Neutral |
| RSI_14 | 48.1 | Neutral |
| MACD Histogram | -0.13 | Bearish |
| vs SMA20 | 0.988x | Below |
| vs SMA50 | 0.984x | Below |
| vs SMA200 | 1.131x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $354.94
- **Stop Loss:** $323.72 (8.8% risk)
- **Target:** $386.16 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 36
- **Position Value:** $12,777.84
- **Portfolio %:** 12.78%
- **Risk Dollars:** $1,150.00
- **Risk Per Trade:** 1.15%
- **Modifiers:** L1 115% | L2 100% | Combined 1.15x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite. VIX remains calm at 14.9 (8th percentile) with positive yield curve (+65bps) and healthy breadth (59.2%), though elevated put/call ratio (1.27) suggests institutional hedging despite surface calm. Focus on quality with awareness of hedging activity divergence.*

### Earnings

**Next:** 2026-02-17 (Est: $2.23)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.12 | $3.04 | -2.6% |
| 2025Q2 | $1.83 | $1.91 | +4.2% |
| 2025Q1 | $2.21 | $2.14 | -3.1% |
| 2024Q4 | $2.14 | $2.44 | +14.1% |

---
*RULE-based L3 | 2026-01-07 09:35 | MRS_10*